|
SIAH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.982100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.023000E-01 |
| Normal-vs-Stage2 |
2.893000E-01 |
| Normal-vs-Stage3 |
4.062200E-02 |
| Normal-vs-Stage4 |
9.662600E-01 |
| Stage1-vs-Stage2 |
9.252000E-01 |
| Stage1-vs-Stage3 |
1.997590E-01 |
| Stage1-vs-Stage4 |
5.915400E-01 |
| Stage2-vs-Stage3 |
3.400400E-01 |
| Stage2-vs-Stage4 |
5.370800E-01 |
| Stage3-vs-Stage4 |
2.140200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.068000E-02 |
| Normal-vs-AfricanAmerican |
3.146600E-01 |
| Normal-vs-Asian |
2.337800E-01 |
| Caucasian-vs-AfricanAmerican |
4.266400E-01 |
| Caucasian-vs-Asian |
8.566000E-01 |
| AfricanAmerican-vs-Asian |
6.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.805600E-02 |
| Normal-vs-Female |
4.303500E-02 |
| Male-vs-Female |
5.150200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.275600E-01 |
| Normal-vs-Extreme_Weight |
2.824400E-01 |
| Normal-vs-Obese |
1.896390E-02 |
| Normal-vs-Extreme_Obese |
8.300600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.800600E-01 |
| Normal_Weight-vs-Obese |
1.149150E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.636000E-01 |
| Extreme_Weight-vs-Obese |
1.487800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.748800E-01 |
| Obese-vs-Extreme_Obese |
3.309800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.519800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.145680E-02 |
| Normal-vs-Age(61-80Yrs) |
2.825200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.773200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.835400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.399360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.024300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.978200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.800700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.196760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.557870E-02 |
| Normal-VS-Type2 PRCC |
9.577000E-01 |
| Normal-VS-KIRP CIMP |
1.346040E-01 |
| Normal-VS-Unclassified PRCC |
3.928100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.953810E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.858000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.761600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.445600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.565900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.658400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.547600E-01 |
| Normal-vs-N1 |
2.078200E-02 |
| Normal-vs-N2 |
5.269600E-02 |
| N0-vs-N1 |
3.139900E-02 |
| N0-vs-N2 |
1.575230E-01 |
| N1-vs-N2 |
2.597500E-02 |
|
|
